Literature DB >> 20335313

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

Kenneth F Schulz1, Douglas G Altman, David Moher.   

Abstract

The CONSORT (Consolidated Standards of Reporting Trials) statement is used worldwide to improve the reporting of randomized, controlled trials. Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience.

Mesh：

Year:  2010        PMID： 20335313     DOI： 10.7326/0003-4819-152-11-201006010-00232

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  989 in total

1.  Explaining the RE-LY Trial.

Authors:  John W Eikelboom; Stuart J Connolly
Journal:  Can J Hosp Pharm       Date:  2010-07

2.  [Basic principles, planning and implementation of non-commercial clinical trials].

Authors:  R P Finger; C Coch; M Coenen; M Mengel; G Hartmann; F G Holz
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

3.  Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment.

Authors:  D Lamunu; K N Chapman; P Nsubuga; G Muzanyi; Y Mulumba; M A Mugerwa; S Goldberg; L Bozeman; M Engle; J Saukkonen; S Mastranunzio; H Mayanja-Kizza; J L Johnson
Journal:  Int J Tuberc Lung Dis       Date:  2012-04       Impact factor: 2.373

4.  Negative randomized clinical trials (RCTs): further insight from the biostatistician's point of view.

Authors:  Bruno Mario Cesana
Journal:  Intensive Care Med       Date:  2015-10-21       Impact factor: 17.440

5.  Acute responses of hemodynamic and oxidative stress parameters to aerobic exercise with blood flow restriction in hypertensive elderly women.

Authors:  Angélica Barili; Vanessa da Silva Corralo; Andréia Machado Cardoso; Aline Mânica; Beatriz da Silva Rosa Bonadiman; Margarete Dulce Bagatini; Marzo Edir Da Silva-Grigoletto; Gabriela Gonçalves de Oliveira; Clodoaldo Antônio De Sá
Journal:  Mol Biol Rep       Date:  2018-07-20       Impact factor: 2.316

6.  Patient-centered and efficacious advance care planning in cancer: Protocol and key design considerations for the PEACe-compare trial.

Authors:  Judith M Resick; Robert M Arnold; Rebecca L Sudore; David Farrell; Shane Belin; Andrew D Althouse; Betty Ferrell; Bernard J Hammes; Edward Chu; Douglas B White; Kimberly J Rak; Yael Schenker
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

7.  Wheelchair skills training to improve confidence with using a manual wheelchair among older adults: a pilot study.

Authors:  Brodie M Sakakibara; William C Miller; Melanie Souza; Viara Nikolova; Krista L Best
Journal:  Arch Phys Med Rehabil       Date:  2013-02-04       Impact factor: 3.966

8.  Randomized controlled trial on the effectiveness of counseling messages for avoiding unprotected sexual intercourse during sexually transmitted infection and reproductive tract infection treatment among female sexually transmitted infection clinic patients.

Authors:  Clive Anderson; Maria F Gallo; Tina Hylton-Kong; Markus J Steiner; Marcia M Hobbs; Maurizio Macaluso; J Peter Figueroa; Denise J Jamieson; Jennifer Legardy-Williams; Jeffrey Wiener; Lee Warner
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

9.  Improving the efficacy of appearance-based sun exposure interventions with the terror management health model.

Authors:  Kasey Lynn Morris; Douglas P Cooper; Jamie L Goldenberg; Jamie Arndt; Frederick X Gibbons
Journal:  Psychol Health       Date:  2014-06-06

10.  Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives.

Authors:  Deborah J Bowen; Jennifer Hay; Hendrika Meischke; Joni A Mayer; Julie Harris-Wai; Wylie Burke
Journal:  Cancer Causes Control       Date:  2018-11-27       Impact factor: 2.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.